Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia

Icahn School of Medicine at Mount Sinai, New York

Montefiore Medical Center, The Bronx

The Jamaica Hospital Medical Center, Jamaica

Johns Hopkins University, Baltimore

Wake Forest University Health Sciences, Winston-Salem

University of North Carolina - Chapel Hill School of Medicine, Chapel Hill

Emory University Hospital Midtown, Atlanta

University of Florida - Jacksonville, Jacksonville

University of Florida (UF) - Division of Infectious Disease, Gainesville

University of South Florida, Tampa

Regional One Healthcare, Memphis

University of Michigan, Ann Arbor

Henry Ford Health System, Detroit

Froedtert Hospital and the Medical College of Wisconsin, Milwaukee

Methodist Hospital Research Institute - Houston, Houston

Rocky Mountain Regional VA Medical Center, Aurora

Banner University Medical Center, Tucson

University of Southern California Keck School of Medicine, Los Angeles

University of California, Los Angeles (UCLA) - Medical Center, Los Angeles

Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance

University of California, San Diego (UCSD) - Medical Center, La Jolla

Tufts Medical Center, Boston

Rhode Island Hospital, Providence

Royal Adelaide Hospital, Adelaide

Monash Health, Clayton

Royal Melbourne Hospital, Melbourne

The Alfred Hospital, Melbourne

Westmead Hospital, Westmead